Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,597 across all filing types
Latest filing 2015-05-15 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
2014年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2014 Annual General Meeting (AGM) of Guangdong Taicheng Pharmaceutical Co., Ltd. It includes information about the meeting date, voting methods, attendance, and the voting results on various proposals such as the 2014 Board Work Report, Supervisory Board Work Report, Financial Statements, Profit Distribution Plan, Annual Report, and the reappointment of the auditing firm. The document also mentions legal opinions confirming the validity of the meeting and voting process. The content is focused on the AGM proceedings and voting outcomes rather than the full annual report or financial statements themselves. The document length is under 5,000 characters and it is a formal announcement of the AGM resolutions and voting results, fitting the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2015-05-15 Chinese
2015年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2015 first extraordinary general meeting of shareholders of Guangdong Taicheng Pharmaceutical Co., Ltd. It includes voting results on multiple proposals, meeting attendance details, and legal opinions confirming the validity of the meeting and voting process. The content focuses on shareholder voting outcomes and meeting procedural details rather than presenting a full report or financial statements. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is substantial and contains detailed voting data, not just a brief announcement or a report publication notice. Therefore, the classification is DVA with high confidence.
2015-05-06 Chinese
2015年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality of the convening, attendance, and voting procedures of a company's 2015 first extraordinary general meeting (临时股东大会). It details the voting results on various proposals, including major asset purchases, financing, and amendments to company bylaws. The document is not a financial report, earnings release, or management discussion, but rather a legal certification of the meeting's procedures and results. It is not a simple announcement but a detailed legal opinion on the shareholder meeting's legality and voting outcomes. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it provides official voting results and legal validation of the shareholder meeting proceedings.
2015-05-06 Chinese
关于召开2015年第一次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2015 first extraordinary general meeting (临时股东大会) of Guangdong Taicheng Pharmaceutical Co., Ltd. It includes the meeting date, agenda items, voting procedures (both onsite and online), registration details, and proxy authorization forms. The content focuses on informing shareholders about the meeting logistics and the matters to be voted on, such as major asset purchases, non-public stock issuance, amendments to company articles, and other corporate governance issues. There are no financial statements or management discussion and analysis included, nor is this a transcript or a report of results. The document is not a report itself but an announcement and notice about the meeting and voting process. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since this document is primarily a notice about the meeting and voting procedures rather than the solicitation materials or proxy statement itself, it aligns best with Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2015-05-04 Chinese
独立董事关于续聘公司审计机构的独立意见
Audit Report / Information Classification · 90% confidence The document is a statement from independent directors regarding the reappointment of the company's audit firm. It references the audit process and compliance with regulations but does not contain financial statements or detailed audit results. The document is short (438 characters) and serves as an opinion or approval related to audit matters rather than a full audit report. Therefore, it fits best under Audit Report / Information (AR), which includes standalone audit reports and related audit opinions, excluding full annual reports. FY 2014
2015-04-24 Chinese
关于召开2014年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2014 Annual General Meeting (AGM) of Guangdong Taicheng Pharmaceutical Co., Ltd. It includes information about the meeting date, location, agenda items to be voted on (including the 2014 annual report, financial statements, profit distribution plan, and audit firm reappointment), voting procedures (both onsite and online), registration details, and proxy authorization forms. The document does not contain the actual annual report or financial statements but rather serves as an official notification to shareholders about the AGM and the matters to be discussed and voted upon. This matches the definition of 'AGM Information' (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM. The document length is over 6,000 characters and is comprehensive in meeting logistics and agenda but does not present financial data or results itself, so it is not an Annual Report (10-K) or Interim Report (IR). Therefore, the correct classification is AGM Information (AGM-R).
2015-04-24 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.